Is it possible that Russia is already effective, secure, and ready for release vaccine covid-19?
The impression arose after the message of the Minister of health of Michael Murashko, published by the information Agency TASS.
According to Ministers, the vaccine will be approved for use for 10 August, and in October will start the vaccination first, doctors and teachers, and then, gradually, the rest of the population.
Most likely, we are talking about the vaccine, developed by the Moscow National research centre of epidemiology and Microbiology named Gamalei. Nits reportedly, the vaccine gives immunity against Sars-CoV and 2, the results of the first tests, has no negative side effects.
Scientific information about the vaccine no
However, the scientific and proven by independent researchers of publications about this vaccine no. Only portal clinicaltrials.gov where scientists and pharmaceutical companies around the world are required to post information about clinical trials and their results, June 18, there was a message from the SIC of Gamaliel, entitled “Study of the safety, tolerability and immunogenicity of a vaccine Gam-Covid-Vac vs covid-19”.
According to the report, we are talking about the vaccine with the gene encoding the S-protein of the virus SARS-CoV-2, will provide immunity to the person vaccinated. In the development of numerous other vaccines — and there are worldwide more than 150 also used the protein. It contains information about the “spikes” in the shell of the virus with which the pathogen attaches to human cells and penetrate into them.
This gene, scientists nits of Gamaliel “Packed” in the adenoviruses type 5 and 26 — a harmless virus that causes a cold. They serve as a means of delivery of vaccine. In the published Protocol of the testing phases of the 1 and 2 States that 38 subjects first injected into the muscle of the dose of adenovirus 26, and three weeks later the dose of adenovirus 5.
However, according to the portal, which was last updated July 7, then subjects have not yet been recruited. It is expected that the study will be completed August 15.
The vaccine as a political tool
For release in wide circulation, the vaccine Gam-Covid-Vac must undergo the third phase of tests on thousands of subjects. So only more or less reliably you can set the effectiveness and, above all, the safety of any vaccine. Therefore, scientists working in the most advanced programmes for developing a vaccine in UK and US, expect to get first results not earlier than in October or November.
According to various reports in the media, the Russian vaccine to pass phase 2 clinical trials, and then — contrary to common practice, in parallel with the vaccination of medical personnel and teachers will be initiated tests of the third phase. Despite this risky procedure, more than 20 countries, including India, Brazil and Saudi Arabia, expressed interest in the vaccine. This was reported by CNN, citing the “Russian officials”.
That for the Russian elite and political considerations play a role, according to statements Kirill Dmitriev, Director of the state Russian direct investment Fund, which holds $ 10 billion and is involved in financing the development of vaccines in the country. “It’s like launching a satellite,” said Dmitriev in an interview with CNN. In 1957 the Soviet Union launched the world’s first artificial Earth satellite into space — now, according to Dmitriev, Russia will gain the first vaccine against covid-19.
